Vanda Pharmaceuticals Inc.
US ˙ NasdaqGM ˙ US9216591084

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Mihael Hristos Polymeropoulos. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Mihael Hristos Polymeropoulos har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:VNDA / Vanda Pharmaceuticals Inc. President and CEO, Director 2.335.731
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Mihael Hristos Polymeropoulos. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb VNDA / Vanda Pharmaceuticals Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i VNDA / Vanda Pharmaceuticals Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2025-08-07 VNDA Polymeropoulos Mihael Hristos 10.000 4,1500 10.000 4,1500 41.500 15 4.7500 6.000 14,46
2025-05-21 VNDA Polymeropoulos Mihael Hristos 9.519 4,4000 9.519 4,4000 41.884
2025-05-21 VNDA Polymeropoulos Mihael Hristos 481 4,3900 481 4,3900 2.112
2025-05-16 VNDA Polymeropoulos Mihael Hristos 20.000 4,2236 20.000 4,2236 84.472
2025-03-06 VNDA Polymeropoulos Mihael Hristos 5.000 5,0200 5.000 5,0200 25.100
2025-03-06 VNDA Polymeropoulos Mihael Hristos 5.000 5,0100 5.000 5,0100 25.050
2025-03-05 VNDA Polymeropoulos Mihael Hristos 5.000 5,0100 5.000 5,0100 25.050
2025-03-05 VNDA Polymeropoulos Mihael Hristos 5.000 5,0300 5.000 5,0300 25.150
2025-03-03 VNDA Polymeropoulos Mihael Hristos 10.000 4,7050 10.000 4,7050 47.050
2025-02-28 VNDA Polymeropoulos Mihael Hristos 10.000 4,7600 10.000 4,7600 47.600
2025-02-27 VNDA Polymeropoulos Mihael Hristos 10.000 4,7600 10.000 4,7600 47.600
2025-02-26 VNDA Polymeropoulos Mihael Hristos 5.000 4,7500 5.000 4,7500 23.750
2025-02-26 VNDA Polymeropoulos Mihael Hristos 5.000 4,7800 5.000 4,7800 23.900
2025-02-25 VNDA Polymeropoulos Mihael Hristos 10.000 4,4640 10.000 4,4640 44.640
2011-08-23 VNDA Polymeropoulos Mihael Hristos 7.920 5,3476 7.920 5,3476 42.353
2011-08-22 VNDA Polymeropoulos Mihael Hristos 2.080 5,3423 2.080 5,3423 11.112

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

VNDA / Vanda Pharmaceuticals Inc. Insider Trades
Insidersalg VNDA / Vanda Pharmaceuticals Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i VNDA / Vanda Pharmaceuticals Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2024-03-05 VNDA Polymeropoulos Mihael Hristos 24.288 4,1285 24.288 4,1285 100.273 13 3.7500 -9.193 -9,17
2024-03-04 VNDA Polymeropoulos Mihael Hristos 30.884 4,2438 30.884 4,2438 131.066
2023-03-03 VNDA Polymeropoulos Mihael Hristos 22.538 6,2506 22.538 6,2506 140.876
2023-03-02 VNDA Polymeropoulos Mihael Hristos 22.426 6,2302 22.426 6,2302 139.718
2022-12-06 VNDA Polymeropoulos Mihael Hristos 48.250 10,6131 48.250 10,6131 512.082
2022-12-05 VNDA Polymeropoulos Mihael Hristos 47.650 10,6233 47.650 10,6233 506.200
2022-03-02 VNDA Polymeropoulos Mihael Hristos 29.588 11,1513 29.588 11,1513 329.945
2022-03-01 VNDA Polymeropoulos Mihael Hristos 7.508 11,1900 7.508 11,1900 84.015
2021-12-01 VNDA Polymeropoulos Mihael Hristos 46.200 16,0032 46.200 16,0032 739.348
2021-11-30 VNDA Polymeropoulos Mihael Hristos 50.000 16,4855 50.000 16,4855 824.275
2021-03-08 VNDA Polymeropoulos Mihael Hristos 175.000 18,0003 175.000 18,0003 3.150.052
2021-03-02 VNDA Polymeropoulos Mihael Hristos 15.206 18,3416 15.206 18,3416 278.902
2021-03-01 VNDA Polymeropoulos Mihael Hristos 7.479 18,4520 7.479 18,4520 138.003
2020-12-15 VNDA Polymeropoulos Mihael Hristos 39.150 12,9973 39.150 12,9973 508.844
2020-12-14 VNDA Polymeropoulos Mihael Hristos 51.049 13,1894 51.049 13,1894 673.306
2020-12-11 VNDA Polymeropoulos Mihael Hristos 35.053 12,8765 35.053 12,8765 451.360
2020-03-03 VNDA Polymeropoulos Mihael Hristos 5.152 10,9752 5.152 10,9752 56.544
2020-03-02 VNDA Polymeropoulos Mihael Hristos 10.428 10,5688 10.428 10,5688 110.211
2020-01-02 VNDA Polymeropoulos Mihael Hristos 9.467 16,0022 9.467 16,0022 151.493
2019-12-12 VNDA Polymeropoulos Mihael Hristos 70.036 16,9820 70.036 16,9820 1.189.351
2019-12-11 VNDA Polymeropoulos Mihael Hristos 72.373 16,9176 72.373 16,9176 1.224.377
2019-05-21 VNDA Polymeropoulos Mihael Hristos 72.872 15,3413 72.872 15,3413 1.117.951
2019-05-20 VNDA Polymeropoulos Mihael Hristos 67.418 15,1159 67.418 15,1159 1.019.084
2019-05-17 VNDA Polymeropoulos Mihael Hristos 77.225 15,5609 77.225 15,5609 1.201.691
2019-03-04 VNDA Polymeropoulos Mihael Hristos 38.166 19,4100 38.166 19,4100 740.802
2019-03-01 VNDA Polymeropoulos Mihael Hristos 6.500 20,2190 6.500 20,2190 131.424
2019-01-03 VNDA Polymeropoulos Mihael Hristos 4.447 26,0410 4.447 26,0410 115.804
2019-01-02 VNDA Polymeropoulos Mihael Hristos 7.733 26,3220 7.733 26,3220 203.548
2019-01-02 VNDA Polymeropoulos Mihael Hristos 3.056 26,9340 3.056 26,9340 82.310
2018-03-01 VNDA Polymeropoulos Mihael Hristos 60.966 18,7154 60.966 18,7154 1.141.003
2018-01-02 VNDA Polymeropoulos Mihael Hristos 170.225 15,2958 170.225 15,2958 2.603.728
2018-01-02 VNDA Polymeropoulos Mihael Hristos 21.535 15,2960 21.535 15,2960 329.399
2017-01-03 VNDA Polymeropoulos Mihael Hristos 23.330 15,4840 23.330 15,4840 361.242
2016-01-04 VNDA Polymeropoulos Mihael Hristos 21.353 8,9600 21.353 8,9600 191.323
2015-09-10 VNDA Polymeropoulos Mihael Hristos 102.162 12,7298 102.162 12,7298 1.300.502
2015-09-09 VNDA Polymeropoulos Mihael Hristos 29.577 12,5092 29.577 12,5092 369.985
2015-05-22 VNDA Polymeropoulos Mihael Hristos 169.238 10,3644 169.238 10,3644 1.754.050
2015-05-21 VNDA Polymeropoulos Mihael Hristos 17.157 10,3332 17.157 10,3332 177.287
2015-03-10 VNDA Polymeropoulos Mihael Hristos 21.900 10,5300 21.900 10,5300 230.607
2013-11-19 VNDA Polymeropoulos Mihael Hristos 8.928 12,0726 8.928 12,0726 107.784
2012-02-16 VNDA Polymeropoulos Mihael Hristos 11.350 4,6920 11.350 4,6920 53.254

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

VNDA / Vanda Pharmaceuticals Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Mihael Hristos Polymeropoulos som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-08-08 2025-08-07 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 10.000 2.335.731 0,43 4,15 41.500 9.693.284
2025-05-21 2025-05-21 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 481 2.325.731 0,02 4,39 2.112 10.209.959
2025-05-21 2025-05-21 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 9.519 2.325.250 0,41 4,40 41.884 10.231.100
2025-05-19 2025-05-16 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 20.000 2.315.731 0,87 4,22 84.472 9.780.721
2025-03-06 2025-03-06 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 5.000 2.295.731 0,22 5,01 25.050 11.501.612
2025-03-06 2025-03-06 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 5.000 2.290.731 0,22 5,02 25.100 11.499.470
2025-03-05 2025-03-05 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 5.000 2.285.731 0,22 5,03 25.150 11.497.227
2025-03-05 2025-03-05 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 5.000 2.280.731 0,22 5,01 25.050 11.426.462
2025-03-04 2025-03-03 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 10.000 2.275.731 0,44 4,70 47.050 10.707.314
2025-03-04 2025-03-01 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
F - Taxes -95.999 2.265.731 -4,06 4,76 -456.955 10.784.880
2025-02-28 2025-02-28 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 10.000 2.361.730 0,43 4,76 47.600 11.241.835
2025-02-27 2025-02-27 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 10.000 2.351.730 0,43 4,76 47.600 11.194.235
2025-02-26 2025-02-26 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 5.000 2.341.730 0,21 4,78 23.900 11.193.469
2025-02-26 2025-02-26 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 5.000 2.336.730 0,21 4,75 23.750 11.099.468
2025-02-25 2025-02-25 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 10.000 2.331.730 0,43 4,46 44.640 10.408.843
2025-02-20 2025-02-18 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
A - Award 450.000 2.321.730 24,04
2024-03-06 2024-03-05 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -24.288 1.871.730 -1,28 4,13 -100.273 7.727.437
2024-03-06 2024-03-04 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -30.884 1.896.018 -1,60 4,24 -131.066 8.046.321
2024-02-21 2024-02-16 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
A - Award 450.000 1.926.902 30,47
2023-03-06 2023-03-03 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -22.538 1.476.902 -1,50 6,25 -140.876 9.231.524
2023-03-06 2023-03-02 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -22.426 1.499.440 -1,47 6,23 -139.718 9.341.811
2023-02-21 2023-02-16 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
A - Award 115.000 1.521.866 8,17
2022-12-07 2022-12-06 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -48.250 1.406.866 -3,32 10,61 -512.082 14.931.210
2022-12-07 2022-12-06 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 75.365 1.455.116 5,46 3,12 235.139 4.539.962
2022-12-07 2022-12-05 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -47.650 1.379.751 -3,34 10,62 -506.200 14.657.509
2022-12-07 2022-12-05 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 74.635 1.427.401 5,52 3,12 232.861 4.453.491
2022-03-02 2022-03-02 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -29.588 1.352.766 -2,14 11,15 -329.945 15.085.099
2022-03-02 2022-03-01 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -7.508 1.382.354 -0,54 11,19 -84.015 15.468.541
2022-03-02 2022-02-28 4 VNDA Vanda Pharmaceuticals Inc.
Stock Option (Right to Buy)
A - Award 275.000 275.000
2022-03-02 2022-02-28 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
A - Award 115.000 1.389.862 9,02
2021-12-02 2021-12-01 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
M - Exercise -71.676 0 -100,00
2021-12-02 2021-12-01 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -46.200 1.274.862 -3,50 16,00 -739.348 20.401.872
2021-12-02 2021-12-01 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 71.676 1.321.062 5,74 4,88 349.779 6.446.783
2021-12-02 2021-11-30 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
M - Exercise -78.324 71.676 -52,22
2021-12-02 2021-11-30 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -50.000 1.249.386 -3,85 16,49 -824.275 20.596.753
2021-12-02 2021-11-30 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 78.324 1.299.386 6,41 4,88 382.221 6.341.004
2021-03-09 2021-03-08 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -175.000 1.221.062 -12,54 18,00 -3.150.052 21.979.482
2021-03-03 2021-03-02 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -15.206 1.396.062 -1,08 18,34 -278.902 25.606.011
2021-03-03 2021-03-01 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -7.479 1.411.268 -0,53 18,45 -138.003 26.040.717
2021-02-26 2021-02-24 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
A - Award 275.000 275.000
2021-02-26 2021-02-24 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
A - Award 115.000 1.418.747 8,82
2020-12-15 2020-12-15 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
M - Exercise -46.663 0 -100,00
2020-12-15 2020-12-15 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -39.150 1.303.747 -2,92 13,00 -508.844 16.945.191
2020-12-15 2020-12-15 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 46.663 1.342.897 3,60 8,75 408.301 11.750.349
2020-12-15 2020-12-14 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
M - Exercise -61.520 46.663 -56,87
2020-12-15 2020-12-14 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -51.049 1.296.234 -3,79 13,19 -673.306 17.096.549
2020-12-15 2020-12-14 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 61.520 1.347.283 4,78 8,75 538.300 11.788.726
2020-12-15 2020-12-11 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
M - Exercise -41.817 108.183 -27,88
2020-12-15 2020-12-11 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -35.053 1.285.763 -2,65 12,88 -451.360 16.556.127
2020-12-15 2020-12-11 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 41.817 1.320.816 3,27 8,75 365.899 11.557.140
2020-03-04 2020-03-03 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -5.152 1.278.999 -0,40 10,98 -56.544 14.037.270
2020-03-04 2020-03-02 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -10.428 1.284.151 -0,81 10,57 -110.211 13.571.935
2020-02-28 2020-02-26 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
A - Award 140.000 140.000
2020-02-28 2020-02-26 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
A - Award 60.000 1.294.579 4,86
2020-01-06 2020-01-02 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -9.467 1.234.579 -0,76 16,00 -151.493 19.755.980
2019-12-13 2019-12-12 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
M - Exercise -85.801 0 -100,00
2019-12-13 2019-12-12 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -70.036 1.244.046 -5,33 16,98 -1.189.351 21.126.389
2019-12-13 2019-12-12 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 85.801 1.314.082 6,99 10,65 913.781 13.994.973
2019-12-13 2019-12-11 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
M - Exercise -89.199 85.801 -50,97
2019-12-13 2019-12-11 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -72.373 1.228.281 -5,56 16,92 -1.224.377 20.779.567
2019-12-13 2019-12-11 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 89.199 1.300.654 7,36 10,65 949.969 13.851.965
2019-05-21 2019-05-21 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
M - Exercise -79.019 0 -100,00
2019-05-21 2019-05-21 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -72.872 1.211.455 -5,67 15,34 -1.117.951 18.585.295
2019-05-21 2019-05-21 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 79.019 1.284.327 6,56 12,55 991.688 16.118.304
2019-05-21 2019-05-20 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
M - Exercise -73.608 79.019 -48,23
2019-05-21 2019-05-20 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -67.418 1.205.308 -5,30 15,12 -1.019.084 18.219.315
2019-05-21 2019-05-20 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 73.608 1.272.726 6,14 12,55 923.780 15.972.711
2019-05-21 2019-05-17 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
M - Exercise -97.373 152.627 -38,95
2019-05-21 2019-05-17 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -77.225 1.199.118 -6,05 15,56 -1.201.691 18.659.355
2019-05-21 2019-05-17 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 97.373 1.276.343 8,26 12,55 1.222.031 16.018.105
2019-03-04 2019-03-04 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -38.166 1.178.970 -3,14 19,41 -740.802 22.883.808
2019-03-04 2019-03-01 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -6.500 1.217.136 -0,53 20,22 -131.424 24.609.273
2019-03-01 2019-02-27 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
A - Award 140.000 140.000
2019-03-01 2019-02-27 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
A - Award 60.000 1.223.636 5,16
2019-01-04 2019-01-03 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -4.447 1.163.636 -0,38 26,04 -115.804 30.302.245
2019-01-04 2019-01-02 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -3.056 1.168.083 -0,26 26,93 -82.310 31.461.148
2019-01-04 2019-01-02 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -7.733 1.171.139 -0,66 26,32 -203.548 30.826.721
2019-01-04 2018-12-24 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
G - Gift -4.000 1.178.872 -0,34
2018-03-02 2018-03-01 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -60.966 1.182.872 -4,90 18,72 -1.141.003 22.137.923
2018-03-02 2018-02-28 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
A - Award 140.000 140.000
2018-03-02 2018-02-28 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
A - Award 60.000 1.243.838 5,07
2018-01-04 2018-01-02 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit
M - Exercise -18.750 37.500 -33,33
2018-01-04 2018-01-02 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit
M - Exercise -12.500 12.500 -50,00
2018-01-04 2018-01-02 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit
M - Exercise -12.500 12.500 -50,00
2018-01-04 2018-01-02 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
M - Exercise -250.000 0 -100,00
2018-01-04 2018-01-02 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -21.535 1.183.838 -1,79 15,30 -329.399 18.107.986
2018-01-04 2018-01-02 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 18.750 1.205.373 1,58
2018-01-04 2018-01-02 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 12.500 1.149.123 1,10
2018-01-04 2018-01-02 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 12.500 1.149.123 1,10
2018-01-04 2018-01-02 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -170.225 1.111.623 -13,28 15,30 -2.603.728 17.003.163
2018-01-04 2018-01-02 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 250.000 1.281.848 24,23 5,76 1.440.000 7.383.444
2018-01-04 2017-12-28 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
G - Gift -10.000 1.031.848 -0,96
2017-03-03 2017-03-01 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
A - Award 275.000 275.000
2017-03-03 2017-03-01 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit
A - Award 200.000 1.041.848 23,76
2017-02-06 2016-12-23 5 VNDA Vanda Pharmaceuticals Inc.
Common Stock
G - Gift -9.000 830.178 -1,07
2017-01-05 2017-01-03 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit
M - Exercise -18.750 56.250 -25,00
2017-01-05 2017-01-03 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit
M - Exercise -12.500 25.000 -33,33
2017-01-05 2017-01-03 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit
M - Exercise -12.500 25.000 -33,33
2017-01-05 2017-01-03 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit
M - Exercise -6.250 0 -100,00
2017-01-05 2017-01-03 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -23.330 850.848 -2,67 15,48 -361.242 13.174.530
2017-01-05 2017-01-03 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 18.750 874.178 2,19
2017-01-05 2017-01-03 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 12.500 855.428 1,48
2017-01-05 2017-01-03 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 12.500 855.428 1,48
2017-01-05 2017-01-03 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 6.250 830.428 0,76
2016-02-17 2016-02-12 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit
A - Award 75.000 75.000
2016-02-17 2016-02-12 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
A - Award 175.000 175.000
2016-02-12 2015-12-28 5 VNDA Vanda Pharmaceuticals Inc.
Common Stock
G - Gift -15.000 801.781 -1,84
2016-01-06 2016-01-04 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit
M - Exercise -12.500 37.500 -25,00
2016-01-06 2016-01-04 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit
M - Exercise -12.500 37.500 -25,00
2016-01-06 2016-01-04 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit
M - Exercise -12.500 25.000 -33,33
2016-01-06 2016-01-04 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit
M - Exercise -6.250 6.250 -50,00
2016-01-06 2016-01-04 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -21.353 839.178 -2,48 8,96 -191.323 7.519.035
2016-01-06 2016-01-04 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 12.500 860.531 1,47
2016-01-06 2016-01-04 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 12.500 860.531 1,47
2016-01-06 2016-01-04 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 12.500 848.031 1,50
2016-01-06 2016-01-04 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 6.250 835.531 0,75
2015-09-11 2015-09-10 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
M - Exercise -147.626 0 -100,00
2015-09-11 2015-09-10 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -102.162 816.781 -11,12 12,73 -1.300.502 10.397.459
2015-09-11 2015-09-10 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 147.626 918.943 19,14 4,73 698.271 4.346.600
2015-09-11 2015-09-09 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
M - Exercise -42.747 147.626 -22,45
2015-09-11 2015-09-09 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -29.577 771.317 -3,69 12,51 -369.985 9.648.559
2015-09-11 2015-09-09 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 42.747 800.894 5,64 4,73 202.193 3.788.229
2015-05-26 2015-05-22 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
M - Exercise -359.815 0 -100,00
2015-05-26 2015-05-22 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -169.238 758.147 -18,25 10,36 -1.754.050 7.857.739
2015-05-26 2015-05-22 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 359.815 927.385 63,40 0,33 119.099 306.964
2015-05-26 2015-05-21 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
M - Exercise -35.806 359.815 -9,05
2015-05-26 2015-05-21 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -17.157 567.570 -2,93 10,33 -177.287 5.864.814
2015-05-26 2015-05-21 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 35.806 584.727 6,52 0,33 11.852 193.545
2015-03-12 2015-03-10 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit
M - Exercise -12.500 37.500 -25,00
2015-03-12 2015-03-10 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit
M - Exercise -12.500 37.500 -25,00
2015-03-12 2015-03-10 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit
M - Exercise -6.250 12.500 -33,33
2015-03-12 2015-03-10 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit
M - Exercise -12.500 12.500 -50,00
2015-03-12 2015-03-10 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -21.900 548.921 -3,84 10,53 -230.607 5.780.138
2015-03-12 2015-03-10 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 12.500 570.821 2,24
2015-03-12 2015-03-10 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 12.500 570.821 2,24
2015-03-12 2015-03-10 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 12.500 570.821 2,24
2015-03-12 2015-03-10 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 6.250 558.321 1,13
2015-02-09 2015-02-05 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
M - Exercise -48.154 0 -100,00
2015-02-09 2015-02-05 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
F - Taxes -24.947 527.071 -4,52 11,28 -281.402 5.945.361
2015-02-09 2015-02-05 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 48.154 552.018 9,56 0,03 1.594 18.272
2014-12-05 2014-12-04 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Units
A - Award 50.000 50.000
2014-12-05 2014-12-04 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
A - Award 150.000 150.000
2014-02-20 2014-02-18 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Units
M - Exercise -6.250 18.750 -25,00
2014-02-20 2014-02-18 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Units
M - Exercise -12.500 25.000 -33,33
2014-02-20 2014-02-18 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Units
M - Exercise -12.500 25.000 -33,33
2014-02-20 2014-02-18 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit
M - Exercise -18.750 0 -100,00
2014-02-20 2014-02-18 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
F - Taxes -17.772 503.864 -3,41 13,46 -239.211 6.782.009
2014-02-20 2014-02-18 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 6.250 521.636 1,21
2014-02-20 2014-02-18 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 12.500 515.386 2,49
2014-02-20 2014-02-18 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 12.500 515.386 2,49
2014-02-20 2014-02-18 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 18.750 490.386 3,98
2013-12-04 2013-12-02 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit
A - Award 50.000 50.000
2013-12-04 2013-12-02 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
A - Award 150.000 150.000
2013-11-21 2013-11-19 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -8.928 471.636 -1,86 12,07 -107.784 5.693.873
2013-07-31 2013-07-29 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit
M - Exercise -25.000 25.000 -50,00
2013-07-31 2013-07-29 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 25.000 480.564 5,49
2013-02-19 2013-02-14 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit
M - Exercise -12.500 37.500 -25,00
2013-02-19 2013-02-14 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit
M - Exercise -12.500 37.500 -25,00
2013-02-19 2013-02-14 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit
M - Exercise -18.750 18.750 -50,00
2013-02-19 2013-02-14 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
F - Taxes -16.836 455.564 -3,56 3,95 -66.502 1.799.478
2013-02-19 2013-02-14 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 12.500 472.400 2,72
2013-02-19 2013-02-14 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 12.500 472.400 2,72
2013-02-19 2013-02-14 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 18.750 447.400 4,37
2012-12-11 2012-12-07 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit
A - Award 50.000 50.000
2012-12-11 2012-12-07 4 VNDA Vanda Pharmaceuticals Inc.
Employee Stock Option (Right to Buy)
A - Award 150.000 150.000
2012-02-21 2012-02-16 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit
M - Exercise -12.500 37.500 -25,00
2012-02-21 2012-02-16 4 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit
M - Exercise -18.750 37.500 -33,33
2012-02-21 2012-02-16 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -11.350 428.650 -2,58 4,69 -53.254 2.011.226
2012-02-21 2012-02-16 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 12.500 440.000 2,92
2012-02-21 2012-02-16 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 18.750 427.500 4,59
2012-02-13 2011-08-23 4/A VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 7.920 408.750 1,98 5,35 42.353 2.185.832
2012-02-13 2011-08-22 4/A VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 2.080 400.830 0,52 5,34 11.112 2.141.354
2012-02-13 2011-02-18 5 VNDA Vanda Pharmaceuticals Inc.
Restricted Stock Unit
M - Exercise -18.750 56.250 -25,00
2012-02-13 2011-02-18 5 VNDA Vanda Pharmaceuticals Inc.
Common Stock
M - Exercise 18.750 408.750 4,81
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)